5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+85.09%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$465M
AUM Growth
–
Cap. Flow
+$465M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Aprea Therapeutics
APRE
|
$131M |
| 2 |
Q32 Bio
QTTB
|
$115M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$59.3M |
| 4 |
Arvinas
ARVN
|
$56.6M |
| 5 |
Cabaletta Bio
CABA
|
$51.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aprea Therapeutics
APRE
$9.09M
| $131M | 28.17% | +2,852,654 | New | +$131M |
|
|
2
Q32 Bio
QTTB
$20.9M
| $115M | 24.66% | +5,535,919 | New | +$115M |
|
|
3
Crinetics Pharmaceuticals
CRNX
$2.92B
| $59.3M | 12.75% | +2,362,286 | New | +$59.3M |
|
|
4
Arvinas
ARVN
$568M
| $56.6M | 12.19% | +1,378,423 | New | +$56.6M |
|
|
5
Cabaletta Bio
CABA
$133M
| $51.3M | 11.03% | +3,669,263 | New | +$51.3M |
|
6
IDEAYA Biosciences
IDYA
$2.15B
| $26M | 5.59% | +3,463,066 | New | +$26M |
|
7
scPharmaceuticals
SCPH
$295M
| $18.4M | 3.96% | +3,253,440 | New | +$18.4M |
|
8
Cidara Therapeutics
CDTX
$1.66B
| $7.71M | 1.66% | +2,006,511 | New | +$7.71M |
|
|
VIVE
9
DELISTED
VIVEVE MED INC
VIVE
| $10K | ﹤0.01% | +8,078 | New | +$10K |
|